Flores Sergio E, Chambers Caitlin C, Borak Kristina R, Zhang Alan L
Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, California, USA.
Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Orthop J Sports Med. 2020 Jul 14;8(7):2325967119900561. doi: 10.1177/2325967119900561. eCollection 2020 Jul.
Although patients have experienced significant improvements after hip arthroscopy for femoroacetabular impingement (FAI), prior studies suggest that women have worse outcomes than men. These previous studies lack comparisons of patient-reported outcome (PRO) scores based on gender with respect to clinical significance measurements, including the minimal clinically important difference (MCID) and patient acceptable symptom state (PASS).
To evaluate outcomes after hip arthroscopy for FAI based on patient gender by prospectively assessing changes in PRO scores, MCID, and PASS.
Cohort study; Level of evidence, 2.
Women and men undergoing hip arthroscopy for FAI were prospectively enrolled, and preoperative radiographic and intraoperative findings were collected. Patients completed the following PRO surveys before surgery and 2 years postoperatively: modified Harris Hip Score (mHHS), Hip disability and Osteoarthritis Outcome Score (HOOS), and 12-Item Short Form Health Survey. Mean scores and percentage of patients reaching MCID and PASS were analyzed.
A total of 131 hips were included (72 women, 59 men). Women had smaller preoperative alpha angles (59.1° vs 63.7°, respectively; < .001) and lower acetabular cartilage injury grade (6.9% vs 22.0% with grade 4 injury, respectively; = .013). Both women and men achieved equivalent significant improvements in PRO scores after surgery (scores increased 18.4 to 45.1 points for mHHS and HOOS). Women and men reached PASS for mHHS at similar rates (76.4% and 77.2%, respectively; = .915). MCID was also achieved at similar rates between women and men for all scores (range, 61.4%-88.9%) except the activities of daily living subscale of the HOOS, in which a greater percentage of women reached MCID compared with men (79.2% vs 62.7%, respectively; = .037). Additional stratification by age group using the median cohort age of 34 years showed no significant differences in PRO improvement based on age group for each gender.
Women can achieve clinically meaningful improvements in PRO scores after hip arthroscopy for FAI. Compared with men, women demonstrated equivalent high rates of achieving MCID and PASS at 2 years after surgery.
尽管髋关节镜治疗股骨髋臼撞击症(FAI)后患者有显著改善,但先前研究表明女性的治疗效果比男性差。这些先前的研究缺乏基于性别对患者报告结局(PRO)评分进行临床意义测量的比较,包括最小临床重要差异(MCID)和患者可接受症状状态(PASS)。
通过前瞻性评估PRO评分、MCID和PASS的变化,基于患者性别评估髋关节镜治疗FAI后的结局。
队列研究;证据等级,2级。
前瞻性纳入接受髋关节镜治疗FAI的女性和男性,收集术前影像学和术中发现。患者在手术前和术后2年完成以下PRO调查:改良Harris髋关节评分(mHHS)、髋关节功能障碍和骨关节炎结局评分(HOOS)以及12项简短健康调查。分析平均评分以及达到MCID和PASS的患者百分比。
共纳入131例髋关节(72例女性,59例男性)。女性术前α角较小(分别为59.1°和63.7°;P<0.001),髋臼软骨损伤分级较低(4级损伤分别为6.9%和22.0%;P=0.013)。女性和男性术后PRO评分均取得了同等显著的改善(mHHS和HOOS评分增加了18.4至45.1分)。女性和男性达到mHHS的PASS的比例相似(分别为76.4%和77.2%;P=0.915)。除HOOS的日常生活活动子量表外,女性和男性在所有评分中达到MCID的比例也相似(范围为61.4%-88.9%),在该子量表中,达到MCID的女性比例高于男性(分别为79.2%和62.7%;P=0.037)。使用队列年龄中位数34岁按年龄组进行额外分层显示,各性别基于年龄组的PRO改善无显著差异。
女性在髋关节镜治疗FAI后可在PRO评分上取得具有临床意义的改善。与男性相比,女性在术后2年达到MCID和PASS的比例相当高。